van der Wee NJA - Search Results

1

Salivary markers of stress system activation and social withdrawal in humans.

Bauduin SEEC, Giltay EJ, van Noorden MS, van der Werff SJA, de Leeuw M, van Hemert AM, van der Wee NJA. Bauduin SEEC, et al. Among authors: van der werff sja, van der wee nja, van noorden ms, van hemert am. J Psychiatr Res. 2021 Apr;136:435-443. doi: 10.1016/j.jpsychires.2020.10.017. Epub 2020 Oct 22. J Psychiatr Res. 2021. PMID: 33160608 Free article.

2

[Genetic neuroimaging].

van der Wee NJ, van Noorden MS, Veltman DJ. van der Wee NJ, et al. Tijdschr Psychiatr. 2009;51(9):665-73. Tijdschr Psychiatr. 2009. PMID: 19760566 Free article. Review. Dutch.

3

Gender differences in clinical characteristics in a naturalistic sample of depressive outpatients: the Leiden Routine Outcome Monitoring Study.

van Noorden MS, Giltay EJ, den Hollander-Gijsman ME, van der Wee NJ, van Veen T, Zitman FG. van Noorden MS, et al. J Affect Disord. 2010 Sep;125(1-3):116-23. doi: 10.1016/j.jad.2009.12.007. Epub 2010 Jan 6. J Affect Disord. 2010. PMID: 20051291

4

Routine outcome monitoring in the Netherlands: practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice.

de Beurs E, den Hollander-Gijsman ME, van Rood YR, van der Wee NJ, Giltay EJ, van Noorden MS, van der Lem R, van Fenema E, Zitman FG. de Beurs E, et al. Clin Psychol Psychother. 2011 Jan-Feb;18(1):1-12. doi: 10.1002/cpp.696. Clin Psychol Psychother. 2011. PMID: 20238371

5

Cardiorespiratory arrest in a healthy volunteer after a single oral dose of 80 mg of the beta-blocker propranolol.

de Rover M, van Noorden MS, Nieuwenhuis S, van der Wee NJ. de Rover M, et al. Neurobiol Learn Mem. 2010 Nov;94(4):576-7. doi: 10.1016/j.nlm.2010.09.002. Epub 2010 Sep 7. Neurobiol Learn Mem. 2010. PMID: 20828628 No abstract available.

6

Pre-adult versus adult onset major depressive disorder in a naturalistic patient sample: the Leiden Routine Outcome Monitoring Study.

van Noorden MS, Minkenberg SE, Giltay EJ, den Hollander-Gijsman ME, van Rood YR, van der Wee NJ, Zitman FG. van Noorden MS, et al. Psychol Med. 2011 Jul;41(7):1407-17. doi: 10.1017/S0033291710002199. Epub 2010 Nov 16. Psychol Med. 2011. PMID: 21078226

7

Vitality predicts level of guideline-concordant care in routine treatment of mood, anxiety and somatoform disorders.

van Fenema EM, van der Wee NJ, Giltay EJ, den Hollander-Gijsman ME, Zitman FG. van Fenema EM, et al. J Eval Clin Pract. 2012 Apr;18(2):441-8. doi: 10.1111/j.1365-2753.2010.01593.x. Epub 2010 Nov 22. J Eval Clin Pract. 2012. PMID: 21091854

8

Reliability and validity of the Global Assessment of Functioning Scale in clinical outpatients with depressive disorders.

Grootenboer EM, Giltay EJ, van der Lem R, van Veen T, van der Wee NJ, Zitman FG. Grootenboer EM, et al. J Eval Clin Pract. 2012 Apr;18(2):502-7. doi: 10.1111/j.1365-2753.2010.01614.x. Epub 2011 Jan 11. J Eval Clin Pract. 2012. PMID: 21223457

9

Beta receptor-mediated modulation of the late positive potential in humans.

de Rover M, Brown SB, Boot N, Hajcak G, van Noorden MS, van der Wee NJ, Nieuwenhuis S. de Rover M, et al. Psychopharmacology (Berl). 2012 Feb;219(4):971-9. doi: 10.1007/s00213-011-2426-x. Epub 2011 Aug 17. Psychopharmacology (Berl). 2012. PMID: 21847570 Free PMC article. Clinical Trial.

10

Prevalence, demographic and clinical characteristics of body dysmorphic disorder among psychiatric outpatients with mood, anxiety or somatoform disorders.

van der Meer J, van Rood YR, van der Wee NJ, den Hollander-Gijsman M, van Noorden MS, Giltay EJ, Zitman FG. van der Meer J, et al. Nord J Psychiatry. 2012 Sep;66(4):232-8. doi: 10.3109/08039488.2011.623315. Epub 2011 Oct 27. Nord J Psychiatry. 2012. PMID: 22029732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page